Marina to Sell off Non-RNAi Asset to Cypress Bioscience

Under the deal, Marina will receive $750,000 up front, and stands to be paid as much as $27 million in milestones.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.

Related Stories